Pubmed:
Crystal structure of 4-(4-chloro-phen-yl)-6-(morpholin-4-yl)pyridazin-3(2H)-one.

dc.contributor.authorAydın, Abdullah
dc.contributor.authorAkkurt, Mehmet
dc.contributor.authorŞüküroğlu, Murat
dc.contributor.authorBüyükgüngör, Orhan
dc.date.accessioned2023-04-09T00:45:49Z
dc.date.accessioned2023-04-12T00:26:16Z
dc.date.available2023-04-09T00:45:49Z
dc.date.available2023-04-12T00:26:16Z
dc.date.issued2015-08-01T00:00:00Z
dc.description.abstractIn the title compound, C14H14ClN3O2, the morpholine ring adopts a chair conformation, with the exocyclic N-C bond in an equatorial orientation. The 1,6-di-hydro-pyridazine ring is essentially planar, with a maximum deviation of 0.014 (1) Å, and forms a dihedral angle of 40.16 (7)° with the plane of the benzene ring. In the crystal, pairs of centrosymmetrically related mol-ecules are linked into dimers via N-H⋯O hydrogen bonds, forming R 2 (2)(8) ring motifs. The dimers are connected via C-H⋯O and C-H⋯Cl hydrogen bonds, forming a three-dimensional network. Aromatic π-π stacking inter-actions [centroid-centroid distance = 3.6665 (9) Å] are also observed. Semi-empirical mol-ecular orbital calculations were carried out using the AM1 method. The calculated dihedral angles between the pyridizine and benzene rings and between the pyridizine and morpholine (all atoms) rings are 34.49 and 76.96°, respectively·The corresponding values obtained from the X-ray structure determination are 40.16 (7) and 12.97 (9)°, respectively. The morpholine ring of the title compound in the calculated gas-phase seems to have a quite different orientation compared to that indicated by the X-ray structure determination.
dc.identifier.doi10.1107/S2056989015012980
dc.identifier.issn2056-9890
dc.identifier.pubmed26396762
dc.identifier.urihttps://hdl.handle.net/20.500.12597/3672
dc.language.isoen
dc.relation.ispartofActa crystallographica. Section E, Crystallographic communications
dc.subjectcrystal structure
dc.subjecthydrogen bonding
dc.subjectpyridazinone derivative
dc.subjectπ–π stacking inter­actions
dc.titleCrystal structure of 4-(4-chloro-phen-yl)-6-(morpholin-4-yl)pyridazin-3(2H)-one.
dc.typeJournal Article
dspace.entity.typePubmed
oaire.citation.issuePt 8
oaire.citation.volume71
relation.isPublicationOfPubmedb6fabe17-8be6-4b6d-a9ce-a2d29cbc948f
relation.isPublicationOfPubmed.latestForDiscoveryb6fabe17-8be6-4b6d-a9ce-a2d29cbc948f

Files